Much of US pharma keeping promise on price hike caps, says report

12 February 2018
globaldata-logo-big

As part of a growing tradition, the new year coincides with a hike in US pharmaceutical prices, with more than 30 drugs seeing an increase in price.

However, after receiving continued criticism from both the public and politicians, it appears that the industry is sticking within a 10% self-imposed price-hike limit, observes data and analytics company GlobalData.

This 10% cap appears to have become a social contract in the pharma industry since 2016, when Ireland-incorporated Allergan (NYSE: AGN) chief executive Brent Saunders pledged to police pricing, stating that Allergan would limit itself to one price increase per year and would only increase prices by single-digit percentages.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical